In 38 patients with acute anterior myocardial infarction or ischaemia, the extent and amplitude of ST segment elvation was measured on the chest wall with a praecordial mapping technique. There was a poor correlation with measurements of clinical severity and with the extent of necrosis as measured by the peak levels of creatine kinase (CK) and the estimated total amwunt of CK released. In two patients ST segment re-elevation occurred without re-elevation of serum CK and in two other patients reinfarction obvious on enzyme re-elevation occurred without changes in ST segments. Praecordial ST segment mapping appears to have a limited role in measuring or monitoring human infarct size and would be an unreliable toolfor evaluation of methods to limit myocardial necrosis. The chest leads of the standard 12-lead electrocardiogram provided sufficient information for clinical evaluation of ST segment elevation.
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It has been shown that the extent of myocardial necrosis after experimental coronary occlusion can be limited by appropriate interventions (Maroko et al., 1971; Braunwald and Maroko, 1974) . Clinical application of these findings is possible only if accurate methods of measuring and following trends in infarct size in patients can be developed. Mapping of the ST segments of the electrocardiogram in the praecordium has been proposed (Maroko etal., 1972; Reid et al., 1974) for this purpose. Despite adequate documentation of the validity of ST segment elevation as an index of infarct size in dogs (Maroko et al., 1971) , it is not known how accurately ST segment changes in the praecordial electrocardiogram reflect changes in human myocardial infarction. Theoretical considerations (Boineau, 1971) and preliminary clinical reports (Reese, Scheidt, and Killip, 1973) The maximum height of the ST segment was measured to the nearest 05 mm from the isoelectric line (TP segment). When the ST segment was upward sloping the maximum height was taken at a point immediately preceding the origin of the T wave (determined in a lead where the T wave was clearly demarcated). This point varied from 0-6 to 0 12 s from the R wave. The recordings and measurements were made throughout by the same observer (VK). The amplitude of the ST segments measured in each recording position were summed and expressed as the sum ST (EST). (Siegel and Cohen, 1967) .
Estimation of cumulated CK release
From the results of the 2-hourly CK estimations, the total amount of CK released was calculated by a modification of the formula of Shell, Kjekshus, and Sobel (1971) . This technique has been previously shown in experimental animals to reflect the total amount of CK released into the serum. Clinical data recording Each patient had past history, admission physical examination, electrocardiogram, and chest x-ray tabulated on admission; haemodynamic complications and arrhythmias were recorded daily. Clinical severity was calculated by the methods of Peel et al. (1962) and Norris et al. (1969) . Survivors were reviewed at 6 weeks to assess physical capacity (NYHA classification).
Results
The EST on day 1 was 102 ±63-5 mm and progressively declined to 62 ±27-4 mm by day 10 (Fig. 1 ). There was a wide variation between patients: the EST on day 1 ranged from 23-5 to 280'5 mm. The standard deviations from the mean EST was >50 per cent for each of days 1 to 10. The trends in EST varied, even for patients with approximately similar clinical and serum enzyme abnormalities (Fig. 2) estimated by the Peel index or the Norris index (Fig. 3) . The EST on day 1 failed to predict haemodynamic or arrhythmic complications during the subsequent hospital course (Table 1) , or physical capacity (NYHA classification) among the survivors at 6 weeks after infarction.
Comparison with peak and cumulated serum CK EST on day 1 correlated approximately with the peak of the 2-hourly and the routine daily serum enzyme estimations (r=0.69, 0-68, respectively), as did EST (r=0.61, 0-52, respectively) (see Table 2 ). These correlations were significant (P<0 05) but there was a wide individual scatter (Fig. 4) Trends in EST compared with trends in serum CK Daily praecordial ST segment maps were compared with CK estimations in 38 patients. In 3 patients re-elevation of EST occurred: on one occasion there was an associated re-elevation in serum enzyme levels indicating reinfarction, but in 2 patients no change in serum enzymes resulted (Fig. 5) .
Conversely, changes in serum enzyme levels Braunwald and Maroko, 1974) that changes in ST segments detected by praecordial mapping will reflect trends in the extent of human myocardial injury. There was a wide day-to-day variation in individual patients and secondary rises in ST segments were not always corroborated with other evidence of reinfarction, such as changes in serum enzyme levels. In several patients, extension of necrosis which was obvious on sequential serum enzyme estimations was not detected in the daily ST segment maps performed in this study. Though it is conceivable that transient ST segment elevation may have occurred between praecordial maps performed each morning, our findings ( Fig. 1) and those of others (Madias, Venkataraman, and Hood, 1975; Mills et al., 1975) indicate that when ST segment elevation does accompany significant myocardial necrosis, it is sufficiently persistent to be detected within 24 hours after the event. Our findings showed an unacceptable disparity between ST segment elevation and serum levels of enzymes known to reflect myocardial necrosis. While serum creatine kinase elevation has been shown to reflect myocardial necrosis in patients dying of myocardial infarction (Mathey et al., 1975) , no such evidence validating ST segment elevation as an index of human myocardial necrosis has been presented.
The extensive experimental work which has shown the relation of ST segment elevation to myocardial necrosis (Maroko et al., 1971 (Maroko et al., , 1972 has been performed in dogs with normal myocardium and localized coronary artery obstruction. When applied to patients with atherosclerotic heart disease who have suffered acute myocardial infarction it appears to measure phenomena that do not necessarily reflect myocardial necrosis. It is evident in the light of current attempts to limit infarct size (Braunwald and Maroko, 1974 ) that interventions cannot be evaluated solely by changes in praecordial ST segment mapping and will need to be combined with other methods which provide a more accurate measurement of myocardial necrosis Norris et al., 1975) .
The possible prognostic significance of persistent ST segment elevation in identifying high risk patients for late sudden death (Wilson and Pantridge, 1973) or those unsuitable for early mobilization (Morris et al., 1974) 
